Valley National Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History

Valley National Advisers’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,505	Closed	-$2K	–	1018
2022 Q3	$2K	Hold	1,505	–	–	﹤0.01%	807
2022 Q2	$3K	Hold	1,505	–	–	﹤0.01%	744
2022 Q1	$3K	Hold	1,505	–	–	﹤0.01%	772
2021 Q4	$4K	Hold	1,505	–	–	﹤0.01%	726
2021 Q3	$7K	Buy	1,505 +1,000	+198%	+$4.82K	﹤0.01%	633
2021 Q2	$3K	Hold	505	–	–	﹤0.01%	761
2021 Q1	$4K	Hold	505	–	–	﹤0.01%	675
2020 Q4	$2K	Hold	505	–	–	﹤0.01%	716
2020 Q3	$3K	Hold	505	–	–	﹤0.01%	637
2020 Q2	$3K	Hold	505	–	–	﹤0.01%	632
2020 Q1	$3K	Hold	505	–	–	﹤0.01%	622
2019 Q4	$5K	Hold	505	–	–	﹤0.01%	616
2019 Q3	$2K	Buy	+505	New	+$4.08K	﹤0.01%	694

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Valley National Advisers's CLVS Position: Q4 2022 in Review

Valley National Advisers sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 1,505 shares — an estimated $2K sold.

Valley National Advisers first reported a position in CLVS in Q3 2019 and held it in 13 quarters. The position peaked at $7K in Q3 2021. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Valley National Advisers reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Valley National Advisers sold 1,505 Clovis Oncology, Inc. shares in Q4 2022, an estimated $2K.
Valley National Advisers first reported a position in Clovis Oncology, Inc. in Q3 2019 and held it in 13 quarters.
Valley National Advisers's Clovis Oncology, Inc. position peaked at $7K in Q3 2021.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Valley National Advisers's 13F filing for Q4 2022, filed 12 Jan 2023.